Detalhe da pesquisa
1.
Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D.
Liver Int
; 44(1): 139-147, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787009
2.
Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment.
Eur J Immunol
; 52(3): 472-483, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843107
3.
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients.
J Viral Hepat
; 30(4): 283-286, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648369
4.
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA.
J Viral Hepat
; 30(7): 597-606, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924318
5.
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trial.
Liver Int
; 43(8): 1663-1676, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183524
6.
Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C.
J Infect Dis
; 226(3): 441-452, 2022 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33517457
7.
Distinct Immune Imprints of Post-Liver Transplantation Hepatitis C Persist Despite Viral Clearance.
Liver Transpl
; 27(6): 887-899, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641215
8.
Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
J Hepatol
; 71(5): 889-899, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31295532
9.
Antiviral treatment and liver-related complications in hepatitis delta.
Hepatology
; 65(2): 414-425, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27770553
10.
Real-world effect of ribavirin on quality of life in HCV-infected patients receiving interferon-free treatment.
Liver Int
; 38(5): 834-841, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28960793
11.
Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up.
Z Gastroenterol
; 55(9): 848-856, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29186639
12.
Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B.
J Infect Dis
; 214(10): 1492-1497, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27609808
13.
Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.
Clin Infect Dis
; 62(5): 561-7, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26611779
14.
Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals.
Gut
; 64(3): 469-82, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24721903
15.
Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting.
Liver Int
; 35(7): 1845-52, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556625
16.
Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders.
Liver Int
; 35(10): 2275-84, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25801095
17.
Compromised function of natural killer cells in acute and chronic viral hepatitis.
J Infect Dis
; 209(9): 1362-73, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24154737
18.
Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection.
Aliment Pharmacol Ther
; 59(6): 752-761, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212890
19.
Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?
J Hepatol
; 68(4): 851-853, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29175536
20.
Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites.
JAMA Netw Open
; 6(7): e2322048, 2023 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410459